Glenside, PA, United States of America

Jayme L Cannon



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Location History:

  • Glenside, PA (US) (2012)
  • Gaithersburg, MD (US) (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jayme L Cannon

Introduction

Jayme L Cannon is a notable inventor based in Glenside, Pennsylvania. He has made significant contributions to the field of vaccine development, holding two patents that showcase his innovative approach to immunology.

Latest Patents

Cannon's latest patents include a "Method for preparation of aluminum hydroxyphosphate adjuvant." This invention relates to methods for preparing amorphous aluminum hydroxyphosphate, where an aluminum salt and a phosphate solution are co-mixed at a constant ratio in the presence of a buffer. The method maintains a constant pH during the reaction, making it particularly applicable for large-scale manufacturing of aluminum phosphate adjuvant, which is used in vaccine formulations. His second patent is for a "15-valent pneumococcal polysaccharide-protein conjugate vaccine composition." This multivalent immunogenic composition consists of 15 distinct polysaccharide-protein conjugates, providing broad coverage against pneumococcal disease, especially in infants and young children.

Career Highlights

Cannon is currently associated with Merck Sharp & Dohme Corporation, where he continues to contribute to advancements in vaccine technology. His work has been instrumental in developing formulations that enhance the efficacy of vaccines.

Collaborations

Some of his notable coworkers include Patrick L Ahl and Michael J Caulfield, who have collaborated with him on various projects related to vaccine development.

Conclusion

Jayme L Cannon's innovative work in vaccine technology and his patents reflect his commitment to improving public health through scientific advancements. His contributions are vital in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…